Clinical Trial Update: Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

View source ↗

Summary

This clinical trial is investigating how the genitourinary microbiome changes in women with overactive bladder who are receiving intradetrusor injections of ona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Alexis Dieter | Conditions: Overactive Bladder (OAB), Urge Incontinence | Status: RECRUITING